Aurobind Vidyarthi
Overview
Explore the profile of Aurobind Vidyarthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Even Z, Meli A, Tyagi A, Vidyarthi A, Briggs N, de Kouchkovsky D, et al.
Immunity
. 2024 Aug;
57(8):1893-1907.e6.
PMID: 39096910
Naive CD4 T cells in specific pathogen-free (SPF) mice are characterized by transcriptional heterogeneity and subpopulations distinguished by the expression of quiescence, the extracellular matrix (ECM) and cytoskeleton, type I...
2.
Vidyarthi A, Craft J
Cell Chem Biol
. 2024 Jul;
31(7):1239-1241.
PMID: 39029453
In a study published in the July issue of Immunity, Li et al. demonstrate that expression of the E3 ubiquitin ligases CBL and CBL-B is downregulated in Tfh cells in...
3.
Pizzurro G, Bridges K, Jiang X, Vidyarthi A, Miller-Jensen K, Colegio O
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444440
Tumor-associated macrophages (TAMs) can be widely heterogeneous, based on their ontogeny and function, and driven by the tissue-specific niche. TAMs are highly abundant in the melanoma tumor microenvironment (TME), usually...
4.
Pizzurro G, Bridges K, Jiang X, Vidyarthi A, Miller-Jensen K, Colegio O
bioRxiv
. 2023 Jun;
PMID: 37333194
Melanomas display high numbers of tumor-associated macrophages (TAMs), which correlate with worse prognosis. Harnessing macrophages for therapeutic purposes has been particularly challenging due to their heterogeneity, based on their ontogeny...
5.
Seth A, Yokokura Y, Choi J, Shyer J, Vidyarthi A, Craft J
J Exp Med
. 2023 Feb;
220(5).
PMID: 36820828
Coordinated gene expression programs enable development and function of T cell subsets. Follicular helper T (Tfh) cells coordinate humoral immune responses by providing selective and instructive cues to germinal center...
6.
Mittal A, Wang M, Vidyarthi A, Yanez D, Pizzurro G, Thakral D, et al.
Sci Rep
. 2021 May;
11(1):10731.
PMID: 34031449
Cutaneous squamous cell carcinomas (cSCC) are among the most commonly diagnosed malignancies, causing significant morbidity and mortality. Tumor-associated macrophage (TAM) expression of arginase is implicated in tumor progression, and therapeutic...
7.
Kurokawa C, Narasimhan S, Vidyarthi A, Booth C, Mehta S, Meister L, et al.
Ticks Tick Borne Dis
. 2020 Sep;
11(6):101529.
PMID: 32993942
Ticks deposit salivary proteins into the skin during a bite to mediate acquisition of a blood meal. Acquired resistance to tick bites has been demonstrated to prevent Borrelia burgdorferi sensu...
8.
Vidyarthi A, Agnihotri T, Khan N, Singh S, Tewari M, Radotra B, et al.
Cancer Immunol Immunother
. 2019 Nov;
68(12):1995-2004.
PMID: 31690954
Glioblastoma is a highly prevalent and aggressive form of primary brain tumor. It represents approximately 56% of all the newly diagnosed gliomas. Macrophages are one of the major constituents of...
9.
Vidyarthi A, Khan N, Agnihotri T, Negi S, Das D, Aqdas M, et al.
Front Immunol
. 2018 Aug;
9:1650.
PMID: 30072995
During tumor progression, macrophages shift their protective M1-phenotype to pro-tumorigenic M2-subtype. Therefore, conversion of M2 to M1 phenotype may be a potential therapeutic intervention. TLRs are important pathogen recognition receptors...
10.
Vidyarthi A, Khan N, Agnihotri T, Siddiqui K, Nair G, Arora A, et al.
PLoS One
. 2017 Mar;
12(3):e0173769.
PMID: 28319170
Tuberculosis continues to be one of the most devastating global health problem. Its diagnosis will benefit in timely initiation of the treatment, cure and therefore reduction in the transmission of...